Mencarelli, L.; Moi, L.; Dewarrat, N.; Monti, M.; Alberio, L.; Ringwald, M.; Swierdzewska, K.; Panagiotis, A.; Ribi, C.
Eosinophilic Granulomatosis with Polyangiitis after mRNA-1273 SARS-CoV-2 Vaccine. Vaccines 2023, 11, 1335.
https://doi.org/10.3390/vaccines11081335
AMA Style
Mencarelli L, Moi L, Dewarrat N, Monti M, Alberio L, Ringwald M, Swierdzewska K, Panagiotis A, Ribi C.
Eosinophilic Granulomatosis with Polyangiitis after mRNA-1273 SARS-CoV-2 Vaccine. Vaccines. 2023; 11(8):1335.
https://doi.org/10.3390/vaccines11081335
Chicago/Turabian Style
Mencarelli, Lucrezia, Laura Moi, Natacha Dewarrat, Matteo Monti, Lorenzo Alberio, Maxime Ringwald, Karolina Swierdzewska, Antiochos Panagiotis, and Camillo Ribi.
2023. "Eosinophilic Granulomatosis with Polyangiitis after mRNA-1273 SARS-CoV-2 Vaccine" Vaccines 11, no. 8: 1335.
https://doi.org/10.3390/vaccines11081335
APA Style
Mencarelli, L., Moi, L., Dewarrat, N., Monti, M., Alberio, L., Ringwald, M., Swierdzewska, K., Panagiotis, A., & Ribi, C.
(2023). Eosinophilic Granulomatosis with Polyangiitis after mRNA-1273 SARS-CoV-2 Vaccine. Vaccines, 11(8), 1335.
https://doi.org/10.3390/vaccines11081335